Clonidine Transdermal System, USP, 0.3 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Covers, Rx only, Manufactured by…
Reason CGMP Deviations: use of an unapproved raw material
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Defective Delivery System: Out of specification for release liner removal force results at the 3-month CRT stability timepoint.
Clonidine Transdermal System, USP 0.3 mg/day, 4 Patches (NDC 51862-455-01) per Carton (51862-455-04), Rx only, Manufactured for: Mayne Pharma Greenville, NC 27834
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Reason CGMP Deviations: use of an unapproved raw material
Reason CGMP Deviations: use of an unapproved raw material
Reason CGMP Deviations: use of an unapproved raw material
Reason Presence of Particulate Matter
Reason CGMP Deviations: Firm went out of business and could no longer continue stability studies.
Tell us which medications you take. If the FDA recalls one, we email you - in plain English, with what to do. Free.